Mandiri Herindo Adiperkasa Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Mandiri Herindo Adiperkasa Tbk. trades at Rp141 (market cap 2.33T, 2.7M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is far larger — about 3.4× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.57M versus 2.7M). Which is the better fit depends on your goals.
| MAHA | RSCH | |
|---|---|---|
Market Cap | 2.33T | 678.4B |
Volume | 2.7M | 25.57M |
Lot | 27K | 255.67K |
Turnover | 378.94M | 6.57B |
Average Price | 140.36 | 256.8 |
Value | 378.94M | 6.57B |
Indicative Equilibrium Price | 142 | 258 |
Indicative Equilibrium Volume | 20 | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →